MetaCap

LifeMD Inc. (LFMD)

NASDAQ: LFMDHealth CareMedical/Nursing ServicesUSD

1.45-0.15 (-9.40%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

LFMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$69.84M
EPS (TTM)
-$0.52
52-week range
1.38 – 5.38
Day range
1.38 – 1.58
Volume / Avg
1.58M / 929.40K
Beta
—

52-week range

$1.38$5.38

LFMD stock today

Shares of LifeMD (LFMD) finished lower on Nov 20 at $1.45, a drop of 9.40% or $0.15 per share, versus the S&P 500's 3.70% decline. Shares are 73.1% below their 52-week high of $5.38, set on May 6, 2026 and 4.7% above the 52-week low of $1.38, near the bottom of the past year's range. LFMD is down 57.6% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 62.5%.

LifeMD has posted a net loss over the last twelve months (EPS of -$0.52), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About LifeMD

Company profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss.

Industry
Medical/Nursing Services
CEO
Mr. Justin Schreiber
Headquarters
New York, NY
Employees
347
Website
lifemd.com

Financial highlights

Full financials

In fiscal 2025, LifeMD generated $194.1 million in revenue, up 25.3% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $14.4 million, for a net margin of 7.4% versus a median of -38.3% in the prior 5 years. Gross margin was 85.7% (down from 86.2%) and operating margin -4.0%.

LifeMD annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$194.06M$154.82M$152.55M$119.03M$92.88M
Growth+25.34%+1.49%+28.15%+28.16%+149.04%
Net income$14.35M$-21.41M$-20.60M$-45.54M$-60.90M
EPS (diluted)$0.25$-0.60$-0.70$-1.57$-2.29

Analyst forecast

Forecast

Consensus (8 analysts)

strong_buy

Avg. price target

$8.13+462.63%

  • Strong buy 0
  • Buy 8
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $5.00High $15.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 12, 2026
EPS actual vs est.
$-0.10 vs $-0.14
Surprise
+28.57%

LFMD news

All LFMD news

LifeMD peers

Health Care sector
LFMD peer companies
CompanyPrice% ChgMarket capCompare
NAKANakamoto Inc.3.44-15.89%$63.11Mvs LFMD
EUDAEUDA Health Holdings Limited Class A15.96-7.69%$47.79Mvs LFMD
AIRSAirSculpt Technologies Inc.0.5907-9.72%$43.67Mvs LFMD
ALPSALPS Group Inc1.15-3.36%$36.43Mvs LFMD
DCGODocGo Inc.0.175+1.98%$17.32Mvs LFMD
CCMConcord Medical Services Holdings Limited ADR3.55-1.11%$15.41Mvs LFMD
BMGLBasel Medical Group Ltd0.3832+20.01%$5.20Mvs LFMD
ATPCAgape ATP Corporation1.16-15.94%$1.16Mvs LFMD

Indexes, lists and sector

LifeMD stock FAQ

What is LifeMD's stock price today?

LFMD last traded at $1.45 as of Nov 20, 4:00 PM EST, down 9.40% on the day. Prices are delayed at least 15 minutes.

Does LifeMD pay a dividend?

No. LifeMD does not currently pay a regular cash dividend.

Who is LifeMD's CEO?

Mr. Justin Schreiber is the chief executive officer of LifeMD Inc., which has about 347 employees.

Has LFMD ever split its stock?

Yes. The most recent LFMD stock split was a 1-for-5 split on Oct 14, 2020.

What is the LFMD 52-week high?

The 52-week high for LFMD is $5.38 and the 52-week low is $1.38. The stock is currently 73.1% below its high.

Compare LFMD